| Sep 22, 2018 |
Sep 25, 2018 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
20.0
|
-22,158
|
-8.33%
|
✗
|
$883K |
| Aug 15, 2018 |
Aug 16, 2018 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
51.3
|
-382
|
-0.14%
|
✗
|
$13.7K |
| May 15, 2018 |
May 16, 2018 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
51.3
|
-382
|
-0.14%
|
✗
|
$17.5K |
| Feb 15, 2018 |
Feb 20, 2018 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
32.5
|
-1,456
|
-0.54%
|
✗
|
$68.5K |
| Feb 9, 2018 |
Feb 12, 2018 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
22.5
|
-4,169
|
-1.55%
|
✗
|
$173.8K |
| Feb 6, 2018 |
Feb 8, 2018 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
90.0
|
+13,513
|
5.27%
|
✗
|
$142.7K |
| Nov 15, 2017 |
Nov 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
41.3
|
-7,000
|
-2.66%
|
✓
|
$105K |
| Aug 15, 2017 |
Aug 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
45.0
|
-9,464
|
-1.80%
|
✓
|
$140.8K |
| May 15, 2017 |
May 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
41.3
|
-12,674
|
-2.36%
|
✓
|
$192.1K |
| Mar 10, 2017 |
Mar 13, 2017 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
47.5
|
-2,500
|
-0.93%
|
✓
|
$50K |
| Feb 14, 2017 |
Feb 16, 2017 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
41.3
|
-14,273
|
-2.61%
|
✓
|
$220.1K |
| Feb 10, 2017 |
Feb 13, 2017 |
Atara Biotherapeutics, Inc.
|
EVP & Chief Strategy Officer |
Sell |
41.3
|
-6,274
|
-2.27%
|
✓
|
$97K |
| Nov 17, 2016 |
Nov 22, 2016 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
51.3
|
-1,480
|
-0.64%
|
✓
|
$27.2K |
| Nov 14, 2016 |
Nov 16, 2016 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
35.0
|
-16,718
|
-3.52%
|
✓
|
$334.4K |
| Aug 15, 2016 |
Aug 17, 2016 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
37.5
|
-5,356
|
-3.56%
|
✓
|
$120K |
| May 16, 2016 |
May 18, 2016 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
37.5
|
-5,427
|
-3.81%
|
✓
|
$86.3K |
| Feb 16, 2016 |
Feb 18, 2016 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
37.5
|
-5,711
|
-4.25%
|
✓
|
$95.8K |
| Nov 16, 2015 |
Nov 18, 2015 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
28.8
|
-7,586
|
-9.53%
|
✓
|
$236.8K |
| Aug 17, 2015 |
Aug 19, 2015 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
12.5
|
-16,489
|
-20.03%
|
✓
|
$820.5K |
| May 15, 2015 |
May 19, 2015 |
Atara Biotherapeutics, Inc.
|
COO |
Sell |
17.5
|
-48,851
|
-42.61%
|
✗
|
$1.8M |